BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - FRA:BAYN - DE000BAY0017 - Common Stock
26.92 EUR
+0.05 (+0.19%)
BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. BAYN may be in some trouble as it scores bad on both profitability and health. BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BAYN was profitable.
BAYN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
In the past 5 years BAYN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of BAYN (-3.25%) is worse than 67.31% of its industry peers.
Looking at the Return On Equity, with a value of -11.25%, BAYN is doing worse than 67.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of BAYN has declined.
BAYN has a Gross Margin of 54.95%. This is in the lower half of the industry: BAYN underperforms 71.15% of its industry peers.
In the last couple of years the Gross Margin of BAYN has declined.
The Profit Margin and Operating Margin are not available for BAYN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BAYN has about the same amout of shares outstanding than it did 1 year ago.
BAYN has about the same amout of shares outstanding than it did 5 years ago.
BAYN has a better debt/assets ratio than last year.
2.2 Solvency
BAYN has an Altman-Z score of 0.78. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.78, BAYN is doing worse than 73.08% of the companies in the same industry.
BAYN has a debt to FCF ratio of 8.37. This is a slightly negative value and a sign of low solvency as BAYN would need 8.37 years to pay back of all of its debts.
BAYN has a worse Debt to FCF ratio (8.37) than 65.38% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that BAYN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.04, BAYN is not doing good in the industry: 63.46% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.78 |
ROIC/WACCN/A
WACC6.58%
2.3 Liquidity
BAYN has a Current Ratio of 1.13. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
BAYN has a worse Current ratio (1.13) than 67.31% of its industry peers.
BAYN has a Quick Ratio of 1.13. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BAYN (0.73) is worse than 73.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.36%.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
3.2 Future
BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.96% yearly.
The Revenue is expected to grow by 1.11% on average over the next years.
EPS Next Y-5.97%
EPS Next 2Y-1.62%
EPS Next 3Y2%
EPS Next 5Y2.96%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
BAYN is valuated cheaply with a Price/Earnings ratio of 5.37.
96.15% of the companies in the same industry are more expensive than BAYN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.19, BAYN is valued rather cheaply.
With a Price/Forward Earnings ratio of 5.51, the valuation of BAYN can be described as very cheap.
BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 94.23% of the companies in the same industry.
BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.50.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.37 | ||
| Fwd PE | 5.51 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit cheaper than 73.08% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 98.08% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.76 | ||
| EV/EBITDA | 8.82 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.62%
EPS Next 3Y2%
5. Dividend
5.1 Amount
BAYN has a yearly dividend return of 0.40%, which is pretty low.
BAYN's Dividend Yield is comparable with the industry average which is at 2.98.
With a Dividend Yield of 0.40, BAYN pays less dividend than the S&P500 average, which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.62%
EPS Next 3Y2%
FRA:BAYN (10/31/2025, 3:36:41 PM)
26.92
+0.05 (+0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.45B
Revenue(TTM)46.17B
Net Income(TTM)-3418000000
Analysts71.43
Price Target29.09 (8.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)0%
PT rev (3m)0.73%
EPS NQ rev (1m)-5.78%
EPS NQ rev (3m)-9.06%
EPS NY rev (1m)0%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.37 | ||
| Fwd PE | 5.51 | ||
| P/S | 0.57 | ||
| P/FCF | 5.76 | ||
| P/OCF | 3.7 | ||
| P/B | 0.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.82 |
EPS(TTM)5.01
EY18.61%
EPS(NY)4.89
Fwd EY18.16%
FCF(TTM)4.67
FCFY17.36%
OCF(TTM)7.28
OCFY27.03%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number59.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.78 |
F-Score4
WACC6.58%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
EPS Next Y-5.97%
EPS Next 2Y-1.62%
EPS Next 3Y2%
EPS Next 5Y2.96%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.11%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y10.7%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -5.97% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -3.69%.